DESCRIPTION 

Glimepiride is a sulfonylurea antidiabetic agent which decreases blood glucose concentration. Metformin is a biguanide type oral antihyperglycemic drug used in the management of type 2 diabetes. It lowers both basal and glucose. Voglibose is used to reduce high post meal glucose level in diabetes mellitus in patients who have been using other diabetic medications.

INDICATIONS:

As third line treatment of Type II diabetes mellitus in adult patients when diet, exercise and the single agents and second line therapy with two drugs do not result in adequate glycemic control.

Dosage:

The usual recommended dose for adults is one tablet of Glimphip-MV twice a day before meals. Additionally, voglibose tablets may be taken before the remaining meal, as prescribed by the physician.

Packing:

Each box contains 10 blister strips of 10 Tablets each.